Strikingly, Black patients with ER + /HER2- and HER2+ breast cancer had significantly higher TMEM doorway score and macrophage density than White ER + /HER2- and HER2+ patients, a difference not observed in TNBC. This evidence concerns the gene ESR1 and breast cancer.